Literature DB >> 23078432

Is it proper to use non-magnified narrow-band imaging for esophageal neoplasia screening? Japanese single-center, prospective study.

Akira Yokoyama1, Katsuro Ichimasa, Tomonari Ishiguro, Yuichi Mori, Haruo Ikeda, Takemasa Hayashi, Hitomi Minami, Seiko Hayashi, Gen Watanabe, Haruhiro Inoue, Shin-ei Kudo.   

Abstract

AIM: Most screening examinations in Japanese general hospitals are carried out by high-definition television-incompatible (non-HD) scopes and non-magnifying endoscopes. We evaluated the narrow-band imaging (NBI) real-time diagnostic yield of esophageal neoplasia in high-risk patients at a general hospital.
METHODS: In a single-center, prospective, non-randomized controlled trial, 117 consecutive screening patients with high risk for esophageal cancer received primary white-light imaging (WLI) followed by NBI and iodine-staining endoscopy (59 by HDTV-compatible [HD] endoscopy and 58 by non-HD endoscopy). The primary aim was to evaluate the diagnostic yield of non-magnified images in diagnosing esophageal neoplasia. The secondary aim was to compare HD endoscopy and non-HD endoscopy in terms of diagnostic performance.
RESULTS: Overall, the sensitivity of NBI for screening of esophageal neoplasia was superior to WLI, and equivalent to iodine staining (92% vs 42%; P < 0.05, 92% vs 100%; ns). The specificity of NBI was equivalent to WLI (89% vs 94%; ns). In HD, NBI sensitivity was equivalent to both iodine staining and WLI (100% vs 75%; ns). In non-HD, NBI sensitivity was equivalent to iodine staining, but WLI sensitivity was significantly inferior to NBI (88% vs 100%; ns, 25% vs 88%; P < 0.05). The NBI specificity was equivalent to WLI not only in HD but also in non-HD (90% vs 96%; ns, 88% vs 93%; ns).
CONCLUSION: In both HD and non-HD endoscopy, NBI is less likely than WLI to miss a lesion. Even with non-HD endoscopy, NBI is suitable for esophageal standard examinations in general hospitals.
© 2012 The Authors. Digestive Endoscopy © 2012 Japan Gastroenterological Endoscopy Society.

Entities:  

Mesh:

Year:  2012        PMID: 23078432     DOI: 10.1111/j.1443-1661.2012.01309.x

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  5 in total

Review 1.  Quality Assurance in Endoscopy: Which Parameters?

Authors:  Ulrike W Denzer
Journal:  Visc Med       Date:  2016-01-29

Review 2.  Endoscopic diagnosis and management of early squamous cell carcinoma of esophagus.

Authors:  Hon-Chi Yip; Philip Wai-Yan Chiu
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 3.  Value of screening endoscopy in evaluation of esophageal, gastric and colon cancers.

Authors:  Tae H Ro; Michelle A Mathew; Subhasis Misra
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

4.  Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis.

Authors:  Flavio Hiroshi Ananias Morita; Wanderley Marques Bernardo; Edson Ide; Rodrigo Silva Paula Rocha; Julio Cesar Martins Aquino; Mauricio Kazuyoshi Minata; Kendi Yamazaki; Sergio Barbosa Marques; Paulo Sakai; Eduardo Guimarães Hourneaux de Moura
Journal:  BMC Cancer       Date:  2017-01-13       Impact factor: 4.430

5.  New Diagnostic Approach for Esophageal Squamous Cell Neoplasms Using Linked Color Imaging and Blue Laser Imaging Combined with Iodine Staining.

Authors:  Masato Tsunoda; Yoshimasa Miura; Hiroyuki Osawa; Tsevelnorov Khurelbaatar; Mio Sakaguchi; Hisashi Fukuda; Alan Kawarai Lefor; Hironori Yamamoto
Journal:  Clin Endosc       Date:  2019-04-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.